Cargando…
Correction: Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
Autores principales: | Hirata, H, Hinoda, Y, Shahryari, V, Deng, G, Tanaka, Y, Tabatabai, Z L, Dahiya, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068093/ https://www.ncbi.nlm.nih.gov/pubmed/29930252 http://dx.doi.org/10.1038/s41416-018-0146-2 |
Ejemplares similares
-
Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
por: Hirata, H, et al.
Publicado: (2014) -
Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells
por: Hirata, H, et al.
Publicado: (2013) -
microRNA-183 is an oncogene targeting Dkk-3 and SMAD4 in prostate cancer
por: Ueno, K, et al.
Publicado: (2013) -
Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2012) -
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
por: Caldwell, G M, et al.
Publicado: (2006)